REGENXBIO Inc. (RGNX) vs Rezolute, Inc. (RZLT)
A side-by-side comparison of REGENXBIO Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RGNX
REGENXBIO Inc.
$7.55HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
RZLT
Rezolute, Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
Total return — RGNX vs RZLT
growth of $100 · dividends reinvested · last 10yRGNX -44.8% (-5.8%/yr)RZLT -94.6% (-25.3%/yr)RGNX compounded faster over this window
Log scale — wide-divergence pair
RGNX RZLT
RGNX vs RZLT: by the numbers
- •RZLT is the larger company ($405M vs $390M market cap).
- •Both run net losses; RZLT's is the smaller (0.00% vs -112.58% net margin).
Metrics side by side
Valuation
| Metric | RGNX | RZLT |
|---|---|---|
| P/S ratio | 2.24 | N/A |
| P/B ratio | 5.44 | 4.03 |
Profitability
| Metric | RGNX | RZLT |
|---|---|---|
| Gross margin | 88.09% | 0.00% |
| Operating margin | -94.08% | 0.00% |
| Net margin | -112.58% | 0.00% |
| ROE | -273.72% | -77.06% |
| ROIC | -54.00% | -81.80% |
Growth (annualized)
| Metric | RGNX | RZLT |
|---|---|---|
| Revenue CAGR (5Y) | 1.59% | N/A |
| Total return CAGR (5Y) | -24.15% | -9.57% |
Frequently asked
- How have RGNX and RZLT total returns compared?
- Over the past 10 years, RGNX delivered -6.47% and RZLT delivered -25.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.